Creating biomaterials to improve blood vessel formation for treating ischemia
Dynamic ECM-Mimicking Biomaterials for Ischemia Treatment
This study is exploring a new way to help people with peripheral artery disease by creating special materials that encourage the growth of new blood vessels, which could improve healing and blood flow in their legs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10996117 on NIH RePORTER |
What this research studies
This research focuses on developing dynamic biomaterials that mimic the extracellular matrix to enhance the formation of new blood vessels in patients with peripheral artery disease (PAD). By using vascular progenitor cells derived from human induced pluripotent stem cells, the study aims to improve the conditions under which these cells can integrate into existing blood vessels. The approach involves engineering hydrogels that provide specific cues to support the growth and connection of new blood vessels, potentially preventing severe complications like limb amputation. Patients may benefit from a novel treatment that promotes healing and recovery of blood flow in affected limbs.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults suffering from peripheral artery disease, particularly those at risk of critical limb ischemia.
Not a fit: Patients with non-cardiovascular related ischemic conditions or those who do not have peripheral artery disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that restore blood flow and prevent limb loss in patients with critical limb ischemia.
How similar studies have performed: Previous research has shown promise in using engineered biomaterials for vascular regeneration, indicating potential success for this innovative approach.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Zoldan, Janeta — University of Texas at Austin
- Study coordinator: Zoldan, Janeta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.